Add-on quetiapine in the treatment of major depressive disorder in elderly patients with cerebrovascular damage

Clinical Practice and Epidemiology in Mental Health

Volumn 3, Issue , 2007, Pages

  Carta, Mauro Giovanni ^a,b   Zairo, Fausta ^a   Mellino, Gisa ^a   Hardoy, Maria Carolina ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b ASL 7 Iglesias   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CITALOPRAM; GABAPENTIN; MIRTAZAPINE; PAROXETINE; QUETIAPINE; SERTRALINE;

ADD ON THERAPY; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OPTIMAL DRUG DOSE; PATIENT ASSESSMENT; RISK ASSESSMENT; SEDATION; SIDE EFFECT; TREATMENT RESPONSE;

EID: 39049161401     PISSN: 17450179     EISSN: None     Source Type: Journal    
DOI: 10.1186/1745-0179-3-28     Document Type: Article

References (17)

1. Anderson DN Treating depression in old age: The reasons to be positive Age Ageing 2001, 30:13-17. 10.1093/ageing/30.1.13 11322666
2. Alexopoulos GS Meyers BS Young RC Kakuma T Silbersweig D Charlson M Clinically defined vascular depression Am J Psychiatry 1997, 154:562-565. 9090349
3. Simpson S Baldwin RC Jackson A Burns AS Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression Psychol Med 1998, 28:1015-1026. 10.1017/S003329179800693X 9794009
4. McIntyre A Gendron A McIntyre A Quetiapine reduces residual depressive and prominent anxiety symptoms in partial responders to selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) with major depression: An 8-week, double-blind, randomized, placebo-controlled study European Psychiatry 2006, 21(Suppl 1):S164.
5. Calabrese JR Keck PE Jr Macfadden W Minkwitz M Ketter TA Weisler RH Cutler AJ McCoy R Wilson E Mullen J A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression Am J Psychiatry 2005, 162:1351-1360. 10.1176/ appi.ajp.162.7.1351 15994719
6. Yan B Bi X He J Zhang Y Thakur S Xu H Gendron A Kong J Li XM Quetiapine attenuates spatial memory impairment and hippocampal neurodegeneration induced by bilateral common carotid artery occlusion in mice Life Sci 2007 81(5):353-61. 10.1016/j.lfs.2007.05.020 17631910
7. Yan B He J Xu H Zhang Y Bi X Thakur S Gendron A Kong J Li XM Quetiapine attenuates the depressive and anxiolytic-like behavioural changes induced by global cerebral ischemia in mice Behav Brain Res 2007, 182(1):36-41. 10.1016/j.bbr.2007.05.002 17568696
8. American Psychiatric Association Diagnostic and Statistical manual for Mental Disorders. Fourth Edition (DSM IV) Washington DC; American Psychiatric Press 1994
9. Folstein MF Folstein SE McHugh PR Mini-mental state, a practical method for grading the cognitive state of patients for the clinician J Pschiat Res 1975, 12:189-198. 10.1016/0022-3956(75)90026-6
10. Hamilton M A rating scale for depression J Neurol Neurosurg Psychiat 1960, 23:56-62. 14399272
11. Guy W Clinical Global Impression ECDEU Assessment Manual for Psychopharmacology, revised Rockville MD: US Department of Health Education and Welfare 1976, 217-222.
12. Hardoy MC Garofalo A Carpiniello B Calabrese JR Carta MG Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder Clin Pract Epidemol Ment Health 2005, 1:7. 1188063 16026618 10.1186/1745-0179-1-7
13. Brawman-Mintzer O Quetiapine monotherapy in patients with Generalized Anxiety Disorder Presented at the 26th Annual Meeting of the Anxiety Disorders Association of America (ADAA) 2006
14. Atmaca M Yildirim H Ozdemir H Ogur E Tezcan E Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine Psychol Med 2007, 37(1):121-9. 10.1017/S0033291706008968 17094813
15. Rainer M Haushofer M Pfolz H Struhal C Wick W Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: Efficacy, safety and cognitive function Eur Psychiatry 2007, 3.
16. Yury CA Fisher JE Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia Psychother Psychosom 2007, 76(4):213-218. 17570959
17. Poewe W Treatment of dementia with Lewy bodies and Parkinson's disease dementia Mov Disord 2005, 20(Suppl 12):S77-82. 10.1002/mds.20544 16092095